ערך בספרים למניה: akoyabio.com (AKYA)

The Akoya Biosciences tissue analysis ecosystem ensures immense customer retention, which is visualized through the book value per share indicator. Meanwhile, the -0.12 value serves as the baseline capital metric. Profitability is based on the monopoly supply of consumables for unique platforms. Business stability is maintained through in-house reagent synthesis, while electronics and optics are partially outsourced.

Akoya Biosciences diversification through the supply of spatial tissue analysis systems establishes a material base that is reflected in the net asset value per share. This metric captures the residual value of capital minus liabilities, allowing for an assessment of the business's asset protection and bankruptcy risk in the absence of operational growth based on the book value per share.